c-myc antagonizes the effect of p53 on apoptosis and p21(WAF1) transactivation in K562 leukemia cells

Oncogene

Volumn 19, Issue 18, 2000, Pages 2194-2204

  Ceballos, Eva ^e   Delgado, M Dolores ^e   Gutierrez, Pilar ^e   Richard, Carlos ^a   Müller, Daniel ^b   Eilers, Martin ^b   Ehinger, Mats ^c   Gullberg, Urban ^c   León, Javier ^d  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e NONE

Author keywords

Apoptosis; K562; Leukemia; Myc; p53; Transactivation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; ESTROGEN RECEPTOR; MESSENGER RNA; MYC PROTEIN; PROTEIN BAX; PROTEIN P21; PROTEIN P53; ZINC;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN K 562; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA TRANSFECTION; ENZYME REGULATION; HUMAN; LEUKEMIA CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; TRANSACTIVATION;

CYTOMEGALOVIRUS;

EID: 0000418970     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203541     Document Type: Article

References (90)

1. Adachi J, Ookawa K, Shiseki M, Okazaki T, Tsuchida S, Morishita K and Yokota J. (1996). Cell Growth Differ., 7, 879-886.
2. Ahuja H, Bar-Eli M, Arlin Z, Advan-i S, Allen SL, Goldman J, Snyder D, Foti A and Cline M. (1991). J. Clin. Invest., 7, 2042-2047.
3. Alarcon RM, Rupnow BA. Graeber TG, Knox SJ and Giaccia AJ. (1996). Cancer Res., 56, 4315-4319.
4. Alimena G, De Cuia MR, Diverio D, Gastaldi R and Nanni M. (1987). Cancer Genet. Cytogenet., 26, 39-50.
5. Amati B, Alevizopoulos K and Vlach J. (1998). Front. Biosci., 3, d250-d268.
6. Amundson SA, Myers TG and Fornace AJ Jr. (1998). Oncogene, 17, 3287-3299.
7. Bates A and Vousden KH. (1999). Cell. Mol. Life Sci., 55, 28-37.
8. Beck Z, Bacsi A, Kovacs E, Kiss J, Kiss A, Balogh E, Telek B, Toth FD, Andirko I, Olah E, Udvardy M and Rak K. (1998). Leuk. Lymphoma, 30, 293-306.
9. Bellon T, Lopez-Rodriguez C, Rubio MA, Jochems G, Bernabeu C and Corbi AL. (1994). Eur. J. Immunol., 24, 41-47.
10. Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H and Foekens JA. (1992). Cancer Res., 52, 1107-1113.
11. Bi S, Lanza F and Goldman JM. (1993). Leukemia, 7, 1840 1845.
12. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, Stewart M, Donehower LA, Onions DE, Neil JC and Cameron ER. (1995). Oncogene, 10, 1717-1723.
13. Bouchard C, Staller P and Eilers M. (1998). Trends Cell Biol., 8, 202-206.
14. Cañelles M, Delgado MD, Hyland KM, Lerga A, Richard C, Dang CV and Leon J. (1997). Oncogene, 14, 1315-1327.
15. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ. (1997). Nat. Med., 3, 1233-1241.
16. Dang CV. (1999). Mol. Cell. Biol., 19, 1-11.
17. Delgado MD, Lerga A, Cañelles M, Gómez-Casares MT and Leon J. (1995). Oncogene, 10, 1659-1665.
18. Delgado MD, Vaque JP, Arozarena I, López-Ilasaca MA, Martinez C, Crespo P and León J. (2000). Oncogene, 19, 783-790.
19. Donzelli M, Bernardi R, Negri C, Prosperi E, Padovan L, Lavialle C, Brison O and Scovassi AI. (1999). Oncogene, 18, 439-448.
20. Ehinger M, Bergh G, Johnsson E, Gullberg U and Olsson I. (1997). Cell Growth Differ., 8, 1127-1137.
21. Ehinger M, Nilsson E, Persson AM, Olsson I and Gullberg U. (1995). Cell Growth Differ., 6, 9-17.
22. Eischen CM, Weber JD, Roussel MF, Sherr CJ and Cleveland JL. (1999). Genes Dev., 13, 2658-2669.
23. Felsher DW and Bishop JM. (1999). Mol. Cell., 4, 199-207.
24. Feinstein E, Gale RP, Reed J and Canaani E. (1992). Oncogene, 7, 1853-1859.
25. Frazier MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP. (1998). Mol. Cell. Biol., 18, 3735-3743.
26. Garte SJ. (1993). Crit. Rev. Oncog., 4, 435-449.
27. Gottlieb TM and Oren M. (1996). Biochim. Biophys. Acta, 1287, 77-102.
28. Grandori C and Eisenman RN. (1997). Trends. Biochem. Sci., 22, 177-181.
29. Grignani F, Lombardi L, Inghirami G, Sterna SL, Cechova K. and Dalla-Favera R. (1990). EMBO J., 9, 3913-3922.
30. Gutierrez MI, Bhatia K, Siwarski D, Wolff L, Magrath IT, Mushinski JF and Huppi K. (1992). Cancer Res., 52, 1032-1235.
31. Hagiyama H, Adachi T, Yoshida T, Nomura T, Miyasaka N, Honjo T and Tsubata T. (1999). Oncogene, 18, 4091-4098.
32. Handa H, Hegde UP, Kotelnikov VM, Mundle SD, Dong LM, Burke P, Rose S, Gaskin F, Raza A and Preisler HD. (1997). Leuk Res., 21, 479-489.
33. Hansen R and Oren M. (1997). Curr. Op. Genet. Dev., 7, 46-51.
34. Henriksson M and Lüscher B. (1996). Adv. Cancer Res., 68, 109-182.
35. Hermeking H and Eick D. (1994). Science, 265, 2091-2094.
36. Hermeking H, Funk JO, Reichert M, Ellwart JW and Eick D. (1995). Oncogene, 11, 1409-1415.
37. Hoffman B and Liebermann DA. (1998). Oncogene, 17, 3351-3357.
38. Hsu B, Marin MC, el-Naggar AK, Stephens LC, Brisbay S and McDonnell TJ. (1995). Oncogene, 11, 175-179.
39. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S and Evan GI. (1997). Science, 278, 1305-1309.
40. Hueber A-O and Evan GI. (1998). Trends Genet., 14, 364-367.
41. Jackson P, Bos E and Braithwaite AW. (1993). Oncogene, 8, 589-597.
42. Jennings BA and Mills KI. (1998). Leuk Res., 22, 899-903.
43. Kirch HC, Flaswinkel S, Rumpf H, Brockmann D and Esche H. (1999). Oncogene, 18, 2728-2738.
44. Kirsch DG and Kastan MB. (1999). J. Clin. Oncol., 17, 3158-3168.
45. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
46. Kobayashi T, Consoli U, Andreeff M, Shiku H, Deisseroth AB and Zhang W. (1995). Oncogene, 11, 2311-2316.
47. Kremenetskaya OS, Logacheva NP, Baryshnikov AY, Chumakov PM and Kopnin BP. (1997). Oncol. Res., 9, 155-166.
48. Law JC, Ritke MK, Yalowich JC, Leder GH and Ferrell RE. (1993). Leuk. Res., 17, 1045-1050.
49. Levine AJ. (1997). Cell, 88, 323-331.
50. Littlewood TD, Hancock DC, Danielian PS, Parker MG and Evan GI. (1995). Nucleic Acids Res., 23, 1686-1690.
51. Lotem J and Sachs L. (1995). Proc. Natl. Acad. Sci. USA., 92, 9672-9676.
52. Mateyak MK, Obaya AJ, Sedivy JM. (1999). Mol. Cell. Biol., 19, 4672-4683.
53. McGahon AJ, Nishioka WK, Martin SJ, Mahboubi A, Cotter TG and Green DR. (1995). J. Biol. Chem., 270, 22625-22631.
54. Melo JV. (1996). Leukemia, 10, 751-756.
55. Metz T, Harris AW and Adams JM. (1995). Cell. 82, 29-36.
56. Michalovitz D, Halevy O and Oren M. (1990). Cell, 62, 671-680.
57. Mitchell KO and El-Deiry WS. (1999). Cell Growth Differ., 19, 223-230.
58. Miller D, Miller DJ, Garcia JV and Lynch CM. (1993). Meth. Enzymol., 217, 581-599.
59. Milner J and Medcalf EA. (1990). J. Mol. Biol., 216, 481-484.
60. Moberg KH, Tyndall WA and Hall DJ. (1992). Cell. Biochem., 49, 208-215.
61. Nakai H and Misawa S. (1995). Leuk. Lymphoma, 19, 213-221.
62. Newcomb EW. (1995). Leuk. Lymphoma, 17, 211-221.
63. Peller S, Yona R, Kopilova Y, Prokocimer M, Goldfinger N, Uysal A, Karabulut HG, Tukun A, Bokesoy I, Tuncman G and Rotter V. (1998). Genes Chrom. Cancer, 21, 2-7.
64. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL and Ross RH. (1996). Mol. Cell. Biol., 16, 1335-1341.
65. Polyak K, Waldman T, He TC, Kinzler KW and Vogelstein B. (1996). Genes Dev., 10, 1945-1952.
66. Preisler HD, Agarwal R, Sato H, Singh PK, Wang ZQ and Sandberg AA. (1990). Eur. J. Cancer, 26, 960-965.
67. Prokocimer M and Rotter V. (1994). Blood, 84, 2391-2411.
68. Ragimov N, Krauskopf A, Navot N, Rotter V, Oren M and Aloni Y. (1993). Oncogene, 8, 1183-1193.
69. Reisman D, Elkind NB, Roy B, Beamon J and Rotter V. (1993). Cell Growth Differ., 4, 57-65.
70. Roy B, Beamon J, Balint E and Reisman D. (1994). Mol. Cell. Biol., 14, 7805-7815.
71. Rupnow BA, Alarcon RM, Giaccia AJ and Knox J. (1998). Cell Death Differ., 5, 141-147.
72. Sakamuro D, Eviner V, Elliott KJ, Showe L, White E and Prendergast GC. (1995). Oncogene, 11, 2411-2418.
73. Selvakumaran M, Lin HK, TjinThamSjin R, Reed JC, Liebermann DA and Hoffman B. (1994). Mol. Cell. Biol., 14, 2352-2360.
74. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
75. Sheikh MS, Rochefort H and Garcia M. (1995). Oncogene, 11, 1899-1905.
76. Sonenshein GE. (1997). J. Immunol., 158, 1994-1997.
77. Stahler F and Roemer K. (1998). Oncogene, 17, 3507-3512.
78. Stuppia L, Calabrese G, Peila R, Guanciali-Franchi P, Morizio E, Spadano A and Palka G. (1997). Cancer Genet. Cytogenet., 98, 28-35.
79. Subler MA, Martin DW and Deb S. (1992). J. Virol., 66, 4757-4762.
80. Taylor WR, Egan SE, Mowat M, Greenberg AH and Wright JA. (1992). Oncogene, 7, 1383-1390.
81. Thompson EB. (1998). Annu. Rev. Physiol., 60, 575-600.
82. Trepel M, Scheding S, Groscurth P, Horny HP, Malipiero U, Brugger W, Dichgans J and Weller M. (1997). Leukemia, 11, 1842-1849.
83. Trudel M, Lanoix J, Barisoni L, Blouin MJ, Desforges M, L'Italien C and D'Agati V. (1997). J. Exp. Med., 186, 1873-18784.
84. Waikel RL, Wang X-J and Roop DR. (1999). Oncogene, 18, 4870-4878.
85. Wagner AJ, Kokontis JM and Hay N. (1994). Genes Dev., 8, 2817-2830.
86. Wallace-Brodeur RR and Lowe SW. (1999). Cell. Mol. Life Sci., 54, 64-75.
87. Wu R, Bellas RE, Shen J and Sonenshein GE. (1998). J. Exp. Med., 187, 1671-1679.
88. Yin XY, Crove L, Datta NS, Long MW and Prochownik EV. (1999). Oncogene, 18, 1177-1184.
89. Zeng Y-X and El-Deiry. (1996). Oncogene, 12, 1557-1564.
90. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.